Xiaoya Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoya Zhang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hengnian Qi
School of Information Engineering, Huzhou Normal University, Huzhou 313000, China
2 shared publications - Qizhe Tang
School of Information Engineering, Huzhou University, Huzhou 313000, China
2 shared publications Chu Zhang
School of Information Engineering, Huzhou University, Huzhou, China
1 shared publication- Chu Zhang
School of Information Engineering, Huzhou Normal University, Huzhou 313000, China
1 shared publication - Chuanhao Fan
Huzhou University
1 shared publication - Jiaxi Liu
Huzhou University
1 shared publication
Latest Publications
- 9 May 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
Early diagnosis of Alzheimer's disease through handwriting analysis and deep learning: A review
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders worldwide, requiring early identification for timely intervention and to slow disease progression. However, existing diagnostic approaches, while effective at later stages, remain limited in detecting early-stage AD. Handwriting analysis has recently emerged as a non-invasive, cost-effective, and ecologically valid digital behavioral biomarker that reflects neurocognitive impairment. This review examines the role of handwriting as a neurocognitive marker for AD, focusing on integrating deep learning methodologies to enhance early diagnostic accuracy. It also elucidates the neurocognitive mechanisms linking handwriting behavior and AD, addressing current methodological and translational challenges. We performed a PRISMA-informed structured literature search and narrative synthesis of handwriting- and drawing-based studies for detecting AD/mild cognitive impairment (MCI), including offline handwriting images and online pen-stroke kinematics captured by digital devices. Task paradigms, data dimensions, preprocessing pipelines, modeling strategies (traditional machine learning and deep learning), evaluation practices, and translational considerations were summarized, and studies were organized by detection purpose and analytic approach. Our findings show that handwriting-based models generally discriminate AD/MCI from healthy controls with accuracy exceeding 80%, while deep learning models (e.g., convolutional neural network and multimodal Transformer fusion) approach 90% in structured tasks like clock drawing and figure copying. Online kinematic markers (e.g., reduced velocity, prolonged in-air time, increased pausing, and pressure instability) recur across studies, and multimodal integration with speech, gait, or facial signals can further improve sensitivity and ecological validity, although most studies are small and single-center.
- 9 May 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
Early diagnosis of Alzheimer's disease through handwriting analysis and deep learning: A review
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders worldwide, requiring early identification for timely intervention and to slow disease progression. However, existing diagnostic approaches, while effective at later stages, remain limited in detecting early-stage AD. Handwriting analysis has recently emerged as a non-invasive, cost-effective, and ecologically valid digital behavioral biomarker that reflects neurocognitive impairment. This review examines the role of handwriting as a neurocognitive marker for AD, focusing on integrating deep learning methodologies to enhance early diagnostic accuracy. It also elucidates the neurocognitive mechanisms linking handwriting behavior and AD, addressing current methodological and translational challenges. We performed a PRISMA-informed structured literature search and narrative synthesis of handwriting- and drawing-based studies for detecting AD/mild cognitive impairment (MCI), including offline handwriting images and online pen-stroke kinematics captured by digital devices. Task paradigms, data dimensions, preprocessing pipelines, modeling strategies (traditional machine learning and deep learning), evaluation practices, and translational considerations were summarized, and studies were organized by detection purpose and analytic approach. Our findings show that handwriting-based models generally discriminate AD/MCI from healthy controls with accuracy exceeding 80%, while deep learning models (e.g., convolutional neural network and multimodal Transformer fusion) approach 90% in structured tasks like clock drawing and figure copying. Online kinematic markers (e.g., reduced velocity, prolonged in-air time, increased pausing, and pressure instability) recur across studies, and multimodal integration with speech, gait, or facial signals can further improve sensitivity and ecological validity, although most studies are small and single-center.
- 20 July 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (1) , 112-127
Optimized sequential classification models for mild cognitive impairment screening based on handwriting and speech data
Background: Handwriting and speech are served as reliable signatures for detecting cognitive decline, playing a pivotal role in the early diagnosing Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, current unimodal approaches for diagnosing AD and MCI have demonstrated constraints in classification accuracy, potentially overlooking the synergistic value of combining handwriting and speech data. Objective: Presenting an innovative multi-modal screening classification model, that harnesses handwriting and speech analysis to enhance MCI detection, aiming to overcome the constraints of single-modality approaches by integrating data from both modalities, thereby improving diagnostic accuracy. Methods: Proposing a multimodal classification model based on gated recurrent unit (GRU) and attention mechanism, treating handwriting and speech data as sequence inputs. The model was constructed and tested on a dataset of 41 participants, including 20 MCI patients and 21 cognitively normal (CN) individuals. To mitigate the risk of overfitting due to the small sample size, we employed a 10-fold cross-validation strategy to ensure the robustness of the results. Results: Our multimodal classification model achieved an accuracy of 95.2% for MCI versus CN individuals, which shows a significant improvement compared to the results of single-modality. This result indicates the effectiveness of the cross-fusion model in enhancing classification performance, offering a promising approach for the early diagnosis of neurodegenerative diseases. Conclusions: The proposed GRU_CA effectively improves early MCI detection by fusing handwriting and speech data, outperforming a single modality. It shows strong potential for deployment in primary healthcare settings and establishes a foundation for future research on more complex diagnostic tasks, including CN, MCI, and AD classification, as well as longitudinal studies.
- 20 July 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (1) , 112-127
Optimized sequential classification models for mild cognitive impairment screening based on handwriting and speech data
Background: Handwriting and speech are served as reliable signatures for detecting cognitive decline, playing a pivotal role in the early diagnosing Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, current unimodal approaches for diagnosing AD and MCI have demonstrated constraints in classification accuracy, potentially overlooking the synergistic value of combining handwriting and speech data. Objective: Presenting an innovative multi-modal screening classification model, that harnesses handwriting and speech analysis to enhance MCI detection, aiming to overcome the constraints of single-modality approaches by integrating data from both modalities, thereby improving diagnostic accuracy. Methods: Proposing a multimodal classification model based on gated recurrent unit (GRU) and attention mechanism, treating handwriting and speech data as sequence inputs. The model was constructed and tested on a dataset of 41 participants, including 20 MCI patients and 21 cognitively normal (CN) individuals. To mitigate the risk of overfitting due to the small sample size, we employed a 10-fold cross-validation strategy to ensure the robustness of the results. Results: Our multimodal classification model achieved an accuracy of 95.2% for MCI versus CN individuals, which shows a significant improvement compared to the results of single-modality. This result indicates the effectiveness of the cross-fusion model in enhancing classification performance, offering a promising approach for the early diagnosis of neurodegenerative diseases. Conclusions: The proposed GRU_CA effectively improves early MCI detection by fusing handwriting and speech data, outperforming a single modality. It shows strong potential for deployment in primary healthcare settings and establishes a foundation for future research on more complex diagnostic tasks, including CN, MCI, and AD classification, as well as longitudinal studies.